Month: March 2018

Addressing the Anti-VEGF Treatment Burden

Drs Rehan Hussain and Ciulla just published in Retina Insider on long-acting and sustained released anti-VEGF therapies… http://www.reviewofophthalmology.com/article/addressing-the-antivegf-treatment-burden Addressing the Anti-VEGF Treatment Burden Rehan M. Hussain, MD, Miami, and Thomas A. Ciulla, MD, MBA, Indianapolis Published 12 March 2018 Addressing the Anti-VEGF Treatment Burden There […]

Real-world Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration in the United States

A co-authored study: Real-world nAMD patients in the US receive fewer anti-VEGF injections and experience worse visual outcomes compared with patients in randomized clinical trials… http://www.ophthalmologyretina.org/article/S2468-6530(17)30297-X/fulltext Real-world Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration in the United States Real-world visual […]